Drostanolone: the cruel hidden enemy boxers should shun

In the world of professional boxing, the pursuit of high performance has led some athletes to cross the line of fair play and many pay the terrible consequences.

One of the most controversial substances on the VADA (Voluntary Anti-Doping Association) blacklist is Drostanolone, an anabolic-androgenic steroid that has raised alarms both inside and outside the ring.

Drostanolone, also known by its trade name Masteron, was originally developed for the treatment of breast cancer in women. However, its non-medical use has gained popularity among athletes seeking to illegally enhance their physical performance, especially in strength and contact sports, specifically boxing.

VADA, which works in conjunction with various boxing commissions and sanctioning bodies such as the World Boxing Council (WBC), maintains a zero-tolerance policy regarding this substance. Classified under category S1: Anabolic Agents by WADA (World Anti-Doping Agency), its use is prohibited both in and out of competition.

The reason is clear: Drostanolone offers advantages such as increased lean muscle mass, reduced body fat, and a noticeable improvement in recovery and physical endurance. These effects not only alter the outcome of the sport, but also put the safety of the opponent at risk, especially in a contact sport as demanding and exacting as boxing.

The list of positive cases is not short. Several boxers have been suspended after testing positive for Drostanolone in anti-doping controls, resulting in severe penalties, loss of titles, and even cancellation of fights.

With increasing vigilance and a commitment to maintaining a clean sport, organizations such as VADA are reinforcing their stance against doping, reminding us that true champions are triumphant with discipline, not chemicals.

If you want to see the list of banned substances issued by VADA, you can check the following link: https://wbcboxing.com/wp-content/uploads/VADA-Prohibited-List-2025.please